Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4370 results

Sort By:

GPR146 and Cholesterol Metabolism

Study ID: NCT07142317
Start Date: 2025-10
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

23

Intervention / Treatment

Cholesterol-poor plant sterol-poor meal

Cholesterol-rich plant sterol-poor arm

Cholesterol-rich plant sterol-rich arm

Sponsor

Maastricht University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Clinical Study on Evaluating the Safety and Effectiveness of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Third-line or Above Treatment

Study ID: NCT07195617
Start Date: 2025-10-10
End Date: 2027-11-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

BCMA-GPRC5D CART

Sponsor

Guangzhou Bio-gene Technology Co., Ltd

Source: clinicaltrials.gov

Share:
Add to list

Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma

Study ID: NCT06957431
Start Date: 2025-09-30
End Date: 2033-09-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

Zantal

Eribulin

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About the Risk of Pregnancy Complications and About the Mother's and Baby's Health

Study ID: NCT05477953
Start Date: 2025-12-31
End Date: 2032-01-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Nifurtimox (BAYA2502)

Sponsor

Bayer

Source: clinicaltrials.gov

Share:
Add to list

Effects of a Cognitive-Engaging Strength Training Program on Health, Physical Condition, and Quality of Life in People With Alzheimer's Disease

Study ID: NCT07022431
Start Date: 2025-10
End Date: 2026-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

34

Intervention / Treatment

Interval strength training

Sponsor

University of Seville

Source: clinicaltrials.gov

Share:
Add to list

Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

Study ID: NCT07125183
Start Date: 2025-12
End Date: 2029-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Doxorubicin

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

Study on Safety and Efficacy of UCB-MNCs for Radiation-induced Lung Injury

Study ID: NCT07177456
Start Date: 2025-10-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

10

Intervention / Treatment

UCB-MNCs

Sponsor

Zhejiang Cancer Hospital

Source: clinicaltrials.gov

Share:
Add to list

Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

Study ID: NCT07142551
Start Date: 2025-10-30
End Date: 2034-06-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Testosterone cypionate

Luteinizing hormone-releasing hormone (LHRH) analogue

Darolutami

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

Socket Preservation Using Socket-plug Technique With Alloplastic Putty Bone Versus Ice Cream Cone Technique in Extraction Socket With Buccal Dehiscence.

Study ID: NCT06655766
Start Date: 2025-10-30
End Date: 2026-02-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

socket-plug technique with putty bone

Ice cream cone technique

Sponsor

Cairo University

Source: clinicaltrials.gov

Share:
Add to list

VR in Undergraduate Anesthesia Training

Study ID: NCT07079059
Start Date: 2025-10-01
End Date: 2027-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

180

Intervention / Treatment

Virtual Reality Training

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Source: clinicaltrials.gov

Share:
Add to list